- Home
- SEDG vs VKTX Comparison
SEDG vs VKTX Comparison
Compare SEDG & VKTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SEDG | VKTX |
|---|---|---|
| Founded | 2006 | 2012 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.7B | 4.0B |
| IPO Year | 2015 | 2014 |
Fundamental Metrics
Financial Performance| Metric | SEDG | VKTX |
|---|---|---|
| Price | $30.91 | $30.79 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 26 | 20 |
| Target Price | $39.50 | ★ $94.82 |
| AVG Volume (30 Days) | 3.0M | ★ 7.1M |
| Earning Date | 11-04-2026 | 10-21-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 78.26 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $1,184,444,000.00 | N/A |
| Revenue This Year | $9.98 | N/A |
| Revenue Next Year | $11.12 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 31.39 | N/A |
| 52 Week Low | $28.21 | $25.77 |
| 52 Week High | $81.25 | $43.15 |
Technical Indicators
Market Signals| Indicator | SEDG | VKTX |
|---|---|---|
| Relative Strength Index (RSI) | 38.52 | 47.15 |
| Support Level | $29.33 | $29.52 |
| Resistance Level | $31.94 | $35.47 |
| Average True Range (ATR) | 1.98 | 2.30 |
| MACD | -0.26 | -0.06 |
| Stochastic Oscillator | 0.89 | 27.41 |
Price Performance
Historical ComparisonAbout SEDG SolarEdge Technologies Inc.
SolarEdge Technologies designs, develops, and sells direct current optimized inverter systems for solar photovoltaic installations. The company system consists of power optimizers, inverters, and cloud-based monitoring platform and addresses a broad range of solar market segments, from residential solar installations to commercial and small utility-scale solar installations. The company sells its products directly to solar installers, engineering, procurement, and construction firms and indirectly to solar installers through distributors and electrical equipment wholesalers.
About VKTX Viking Therapeutics Inc.
Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, and VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype-selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.